Solid pharmaceutical formulation for a pipeazine urea derivative
Details for Australian Patent Application No. 2002333896 (hide)
International Classifications
Event Publications
13 February 2003 Complete Application Filed
Priority application(s): 101 52 351.3 18.10.01 DE
3 July 2003 Application Open to Public Inspection
Published as AU-B-2002333896
5 August 2004 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 06 Jul 2004
26 July 2007 Application Accepted
Published as AU-B-2002333896
2 August 2007 Change of Name(s) of Applicant(s), Section 104
Schering AG The name of the applicant has been changed to Bayer Schering Pharma Aktiengesellschaft 2003
29 November 2007 Standard Patent Sealed
21 February 2008 Amendment Made
The nature of the amendment is: Amend the invention title to read Solid pharmaceutical formulation for a piperazine urea derivative
30 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002333897-NEW DRY AND AQUEOUS EPINASTINE-SYRUP-FORMULATION
2002333895-Methods for preventing and treating bone loss with steroid compounds
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser